Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary …

D Sibbing, D Aradi, D Alexopoulos, J Ten Berg… - JACC: Cardiovascular …, 2019 - jacc.org
Dual-antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the standard
treatment for patients undergoing percutaneous coronary intervention. The availability of …

Trauma-induced coagulopathy

EE Moore, HB Moore, LZ Kornblith, MD Neal… - Nature reviews Disease …, 2021 - nature.com
Uncontrolled haemorrhage is a major preventable cause of death in patients with traumatic
injury. Trauma-induced coagulopathy (TIC) describes abnormal coagulation processes that …

[PDF][PDF] 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

M Roffi, C Patrono, JP Collet, C Mueller… - Polish Heart …, 2015 - journals.viamedica.pl
5. Leczenie.............................................................. 1225 5.1. Farmakoterapia
niedokrwienia...................... 1225 5.1. 1. Ogólne leczenie objawowe................. 1225 5.1. 2 …

Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014

RA Byrne, M Joner, A Kastrati - European heart journal, 2015 - academic.oup.com
Modern-day stenting procedures leverage advances in pharmacotherapy and device
innovation. Patients treated with contemporary antiplatelet agents, peri-procedural …

Platelet function tests: a comparative review

R Paniccia, R Priora… - Vascular health and …, 2015 - Taylor & Francis
In physiological hemostasis a prompt recruitment of platelets on the vessel damage prevents
the bleeding by the rapid formation of a platelet plug. Qualitative and/or quantitative platelet …

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study

GW Stone, B Witzenbichler, G Weisz, MJ Rinaldi… - The Lancet, 2013 - thelancet.com
Background The relation between platelet reactivity and stent thrombosis, major bleeding,
and other adverse events after coronary artery implantation of drug-eluting stents has been …

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate

L Bonello, US Tantry, R Marcucci, R Blindt… - Journal of the American …, 2010 - jacc.org
The addition of clopidogrel to aspirin treatment reduces ischemic events in a wide range of
patients with cardiovascular disease. However, recurrent ischemic event occurrence during …

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

NJ Breet, JW van Werkum, HJ Bouman, JC Kelder… - Jama, 2010 - jamanetwork.com
Context High on-treatment platelet reactivity is associated with atherothrombotic events
following coronary stent implantation. Objective To evaluate the capability of multiple platelet …

Antiplatelet agents for the treatment and prevention of coronary atherothrombosis

C Patrono, J Morais, C Baigent, JP Collet… - Journal of the American …, 2017 - jacc.org
Antiplatelet drugs provide first-line antithrombotic therapy for the management of acute
ischemic syndromes (both coronary and cerebrovascular) and for the prevention of their …

First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in …

K Görlinger, D Dirkmann, AA Hanke… - The Journal of the …, 2011 - pubs.asahq.org
Introduction Blood transfusion is associated with increased morbidity and mortality. We
developed and implemented an algorithm for coagulation management in cardiovascular …